IE 11 is not supported. For an optimal experience visit our site on another browser.

Low levels of chemical that’s been linked to cancer discovered in Zantac

01:14

The FDA issued an alert that Zantac and its generic versions contain low levels of a probable human carcinogen called NDMA, but it is not calling for individuals to stop taking the drug as the agency continues to investigate.